EMMAC: Curaleaf CEO Touts Potential of European Cannabis Market on Back of $286M Acquisition | News Break

U.S. cannabis company Curaleaf agreed to acquire London-based Emmac Life Sciences in a $286 million deal that represents the company's first step into the burgeoning European cannabis market. "We think, although the market is just emerging, it's the addressable opportunity in Europe could actually be bigger than the addressable opportunity...